These sources provide a comprehensive clinical overview of Bartter and Gitelman syndromes, which are rare genetic disorders that disrupt the kidneys' ability to reabsorb salt and essential minerals. They describe how mutations in genes such as SLC12A3 and CLCNKB lead to characteristic imbalances, specifically hypokalaemia (low potassium) and hypomagnesaemia (low magnesium). While Bartter syndrome often presents in infancy with severe symptoms like polyhydramnios and growth delays, Gitelman syndrome typically appears in adolescence or adulthood through fatigue and muscle cramps. Diagnosis is established via biochemical screening and confirmed through genetic testing to identify specific inheritance patterns. Long-term management focuses on lifelong electrolyte supplementation and monitoring for complications like chronic kidney disease or cardiac arrhythmias. Overall, the literature suggests that while these conditions are chronic, early detection and consistent treatment allow most patients a satisfactory prognosis.